Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 24, 2016

View Archived Issues

Antimitotic compound leiodermatolide reduces pancreatic tumor weights in vivo

IdeS reduces HLA antibodies in kidney transplant candidates

Novel compound E-6887 shows promise for treating lupus

U.S. HHS awards contracts to support development of Zika virus diagnostic tests

Hemispherx Biopharma's NDA for rintatolimod receives approval in Argentina

Orally available peptides from Protagonist Therapeutics show promise for treating IBD

Biotron identifies new compounds in Zika program, signs agreement with NIAID

EMA validates Cempra's MAA for solithromycin

Oncology Venture updates progress of phase I trial of LiPlaCis

Innovative Targeting Solutions signs agreement with Janssen Biotech

FORMA Therapeutics describes HDAC inhibitors

Immune Therapeutics initiates Malawi study of LDN for prevention of cervical cancer

FDA grants breakthrough status to Stemline's SL-401

Cyon Therapeutics licenses Novartis' anti-PCSK9 antibody LGT-209

Temple University discovers novel 5-HT7 antagonists to treat inflammatory bowel disease

Pfizer to acquire AstraZeneca's small molecule anti-infectives business

FDA accepts Clovis' NDA for rucaparib

GlaxoSmithKline and Astex present a novel potent and reversible inhibitor of PAF acetylhydrolase

Biocardia merges with Tiger X Medical, forms new entity

AiCuris Anti-infective Cures' pritelivir achieves primary endpoint in phase I trial

Nanoantibiotics changes name to Biovie

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...